Previously, our group found that EIF4G1 expression is significantly higher in NSCLC tissues than in paraneoplastic tissues and affects patient prognosis, such that high expression of EIF4G1 in tumor tissues predicts shorter patient survival (Bai et al., 2023). This evidence concerns the gene EIF4G1 and neoplasm.